Cargando…
Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentin
OBJECTIVE: We compared methods used with current recommendations for synthesizing harms in systematic reviews and meta-analyses (SRMAs) of gabapentin. STUDY DESIGN & SETTING: We followed recommended systematic review practices. We selected reliable SRMAs of gabapentin (i.e., met a pre-defined li...
Autores principales: | Qureshi, Riaz, Mayo-Wilson, Evan, Rittiphairoj, Thanitsara, McAdams-DeMarco, Mara, Guallar, Eliseo, Li, Tianjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875742/ https://www.ncbi.nlm.nih.gov/pubmed/34742789 http://dx.doi.org/10.1016/j.jclinepi.2021.10.024 |
Ejemplares similares
-
Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harms
por: Qureshi, Riaz, et al.
Publicado: (2022) -
Summaries of harms in systematic reviews are unreliable Paper 1: An introduction to research on harms
por: Qureshi, Riaz, et al.
Publicado: (2022) -
Comparing the Value of Data Visualization Methods for Communicating Harms in Clinical Trials
por: Qureshi, Riaz, et al.
Publicado: (2022) -
Conducting separate reviews of benefits and harms could improve systematic reviews and meta-analyses
por: Mayo-Wilson, Evan, et al.
Publicado: (2023) -
Probiotics for glycemic control in patients with type 2 diabetes mellitus: protocol for a systematic review
por: Rittiphairoj, Thanitsara, et al.
Publicado: (2019)